, Volume 69, Issue 1, pp 5–9 | Cite as

Imipramine and REM sleep: Cholinergic mediation in animals

  • Shirley Y. Hill
  • Renato B. Reyes
  • David J. Kupfer
Original Investigations


To date it has not been established whether the anticholinergic properties of imipramine are responsible for the drug's suppression of REM and prolongation of REM induction. A cholinesterase inhibitor, physostigmine, was administered in conjunction with imipramine to determine if these effects of imipramine were cholinergically medicated. Sleep EEG recordings were observed in rats administered either physostigmine (1.0 mg/kg), or imipramine (1.25, 2.5, or 5.0 mg/kg), alone or in combination. The results indicate that physostigmine blocks the effects of imipramine on REM latency.

Key words

Imipramine Sleep Physostigmine REM sleep Animals 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Domino, E. F., Yamamoto, K., Dren, A. T.: Role of cholinergic mechanisms in states of wakefulness and sleep. In: Anticholinergic drugs and brain function in animals and man. Progress in brain research, vol. 28, P. B. Bradley, M. Fink, eds, pp. 113–133. Amsterdam: Elsevier 1968Google Scholar
  2. Dunleavy, D. L. E., Brezinova, V., Oswald, I., Maclean, A. W., Tinker, M.: Changes during weeks in effects of tricyclic drugs on the human sleeping brain. Br. J. Psychiatry 120, 663–672 (1972)Google Scholar
  3. Gillin, J. C., Sitaram, N., Mendelson, W. B., Wyatt, R. J.: Physostigmine alters onset but not duration of REM sleep in man. Psychopharmacology 58, 111–114 (1978)Google Scholar
  4. Glenn, L. L., Mancina, R. A., Dement, W. C.: Antidepressants and REM sleep: II. Neurochemical substrates. Sleep Res. 6, 70 (1978)Google Scholar
  5. Hill, S. Y., Reyes, R. B.: Effects of l-tryptophan and ethanol on sleep parameters in the rat. Psychopharmacology 58, 229–233 (1978a)Google Scholar
  6. Hill, S. Y., Reyes, R. B.: Effects of chronic and acute ethanol administration on sleep in laboratory rats. J. Stud. Alcohol 39, 47–55 (1978b)Google Scholar
  7. Hill, S. Y., Reyes, R. B., Kupfer, D. J.: Physostigmine induction of REM sleep in imipramine treated rats. Commun. Psychopharm. 3, 261–266, (1979)Google Scholar
  8. Karczmar, A. G., Longo, V. G., Scotti de Carolis, A.: A pharmacological model of paradoxical sleep: the role of cholinergic and monoamine systems. Physiol. Behav. 5, 175–182 (1970)Google Scholar
  9. Khazan, N., Sulman, F. G.: Effect of imipramine on paradoxical sleep in animals with reference to dreaming and enuresis. Psychopharmacologia 10, 89–95 (1966)Google Scholar
  10. Khazan, N., Bar, R., Sulman, F. G.: The effect of cholinergic drugs on paradoxical sleep in the rat. Int. J. Neuropharm. 6, 279–282 (1967)Google Scholar
  11. Kupfer, D. J.: EEG sleep correlates of depression in man. In: Animal models in psychiatry and neurology, I. Hanin and E. Usdin, eds., pp. 181–188. New York: Pergamon 1978Google Scholar
  12. Kupfer, D. J., Hanin, I., Spiker, D. G., Neil, J., Coble, P.: EEG sleep and tricyclic plasma levels in primary depression. Commun. Psychopharm. 3, 73–80 (1979)Google Scholar
  13. Ritvo, E. R., Ornitz, E. M., LaFranchi, S., Walter, R. D.: Effects of imipramine on the sleep-dream cycle: An EEG study in boys. Electroencephalogr. Clin. Neurophysiol. 22, 465–468 (1967)Google Scholar
  14. Roth, B., Faber, J., Nevsimalova, S., Tosovsky, J.: The influence of imipramine, dexphenmetrazine and amphetaminsulphate upon the clinical and polygraphic picture of narcolepsy-cataplexy. Arch. Suisses Neurol. Neurochirur. Psychiatr. 108, 251–260 (1971)Google Scholar
  15. Saletu, B., Allen, M., Itil, T. M.: The effect of coca-cola, caffeine, antidepressants, and chlorpromazine on objective and subjective sleep parameters. Pharmakopsychiat. Neuropsychopharmacol. 254, 307–321 (1974)Google Scholar
  16. Sitaram, N., Mendelson, W. B., Wyatt, R. J., Gillin, J. C.: The time dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep. Brain Res. 122, 562–567 (1977)Google Scholar
  17. Sitaram, N., Wyatt, R. J., Dawson, S., Gillin, J. C.: REM sleep induction by physostigmine infusion during sleep. Science 191, 1281–1283 (1976)Google Scholar
  18. Takahashi, Y., Kipnis, D. M., Daughaday, W. H.: Growth hormones secretion during sleep. J. Clin. Invest. 47, 2079–2090 (1968)Google Scholar
  19. Trabucchi, M., Cheney, D. L., Hanin, I., Costa, E.: Application of principles of steady-state kinetics to the estimation of brain acetylcholine turnover rate: Effects of oxotremorine and physostigmine. J. Pharm. Exp. Ther. 194, 57–64 (1975)Google Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • Shirley Y. Hill
    • 1
  • Renato B. Reyes
    • 1
  • David J. Kupfer
    • 1
  1. 1.Department of PsychiatryUniversity of Pittsburgh School of Medicine, Western Psychiatric Institute and ClinicPittsburgh

Personalised recommendations